New autism therapy shows surprising benefits even in adult mice

**Possible? Yes. Weirdly unlikely? That’s exactly what the old textbooks would say.** For decades, we’ve been told autism is a hardwired developmental condition — a brain locked in by childhood. This study doesn’t just rattle that cage; it kicks the door off its hinges. Blocking the glycine transporter SLC6A20 restored social and communication behaviors in *adult* mice, not just neonates. The adult brain, it turns out, may be far more treatable than we ever gave it credit for. **Why this matters:** It shifts the entire therapeutic horizon. We’ve been obsessed with early intervention because we assumed plasticity fades. But if a single molecular target can rewire behavior in a fully mature brain — and the effects hold in human organoids — then we’re not looking at a stopgap. We’re looking at a potential off-switch for a whole class of neurodevelopmental symptoms, regardless of age. The brain isn't a finished sculpture; it's wet clay that never fully dries. **What it signals:** Beyond autism, this is a broader rallying cry for “adult neuroplasticity” as a treatable frontier. Glycine signaling is ancient and widespread — messing with one transporter could ripple into epilepsy, schizophrenia, even aging. We’re not curing autism here; we're showing that the *brain itself* is not the immutable fortress we feared. It's a leaky, changeable, gloriously stubborn organ that might just surprise us all. **Closer:** The hardest lock in neuroscience wasn’t the synapse — it was our own assumption that some doors never open. This study just picked that lock with a molecule and a mouse. Stay tuned. {"key_insight":"Adult brains retain surprising treatability for neurodevelopmental conditions, challenging the critical window dogma.","confidence":0.72}